Alector: Q4 Of 2025 FTD-GRN Treatment Data Is Important Inflection PointBy mariocazombo76@gmail.com / March 13, 2025
Akero: Reversal Of Cirrhosis With EFX Is A ‘First’ In F4 MASH Patients January 28, 2025 / AKRO, MDGL, NONOF, NVO, Terry Chrisomalis, VKTX / By mariocazombo76@gmail.com
Atai Life Sciences: Positive BPL-003 Data In AUD Leads To Another Catalyst January 29, 2025 / ATAI, CMPS, Terry Chrisomalis / By mariocazombo76@gmail.com
By
/ March 13, 2025 By
/ March 13, 2025 By
/ March 13, 2025 By
/ March 13, 2025 By
/ March 13, 2025 By
/ March 13, 2025